Fatigue and Depression in Chronic HCV Infected Patients Treated with DAAS

Riham Magdy Mahmoud;

Abstract


Abstract:
Introduction and aim:
Fatigue is probably the most common extra hepatic manifestation of HCV infection as about 60% report disabling chronic fatigue also depression has been reported in about one third of HCV-infected patients. The study aimed to evaluate fatigue and depression in hepatitis C virus (HCV) patients before and after treatment (4 weeks and 3 months) by Direct Acting Antiviral Drugs (DAAs).


Other data

Title Fatigue and Depression in Chronic HCV Infected Patients Treated with DAAS
Other Titles الارهاق و الاكتئاب فى مرضى التهاب الكبد المزمن الفيروسى سى المعالجين بمضادات الفيروسات التى تعمل بشكل مباشر
Authors Riham Magdy Mahmoud
Issue Date 2018

Attached Files

File SizeFormat
J9181.pdf920.11 kBAdobe PDFView/Open
Recommend this item

Similar Items from Core Recommender Database

Google ScholarTM

Check

views 2 in Shams Scholar


Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.